% Expired Patents = 16.7

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 43

Loading Chart...

11 inventors (with patents filed for the assignee):

Tatsuki Yokoseki (6 out of 6 patents)

Yasuhide Okamoto (3 out of 3 patents)

Makoto Umeda (3 out of 3 patents)

4. Toshiyuki Ito (3 out of 7 patents)

5. Yukiho Imai (3 out of 4 patents)

6. Shinobu Fujii (3 out of 3 patents)

7. Naofumi Takamatsu (3 out of 3 patents)

8. Etsuro Matsubara (3 out of 3 patents)

9. Masao Shibata (3 out of 6 patents)

10. Tsuguo Kubota (19 patents)

11. Nobuyuki Suzuki (0 patent)

6 patents: Sort by Forward Citations

1. 9090680 - Antibodies that specifically bind to abeta oligomers and uses thereof (2015-07-28),

2. 9090679 - Antibodies that specifically bind to A beta oligomers and use thereof (2015-07-28),

3. 9085614 - Antibodies that specifically bind to Aβ oligomers and uses thereof (2015-07-21),

4. 8858949 - Antibodies that specifically bind to a beta oligomers and use thereof (2014-10-14),

5. 8613924 - Antibodies that specifically bind to A beta oligomers and use thereof (2013-12-24),

6. 8378081 - Antibodies that specifically bind to Aβ oligomers and uses thereof (2013-02-19),

Company Overview

Immunas Pharma, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for infectious diseases. Our focus is on creating effective and safe vaccines and treatments for a range of pathogens, including viruses and bacteria. With a team of experienced scientists and cutting-edge technology, we are committed to advancing the field of immunology and making a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#217 in Kanagawa

#5,990 in Japan

Kanagawa, Japan

Immunas Pharma, Inc.

Forward Citations = 43

11 inventors:

Tatsuki Yokoseki (6 out of 6 patents)

Yasuhide Okamoto (3 out of 3 patents)

Makoto Umeda (3 out of 3 patents)

4. Toshiyuki Ito (3 out of 7 patents)

5. Yukiho Imai (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunas Pharma, Inc.. Retrieved from https://idiyas.com/company/immunas-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]